Rare Disease Genetic Testing Market to Reach $3,102.4 Million by 2032, Growing at a 13.2% CAGR

𝐓𝐡𝐞 𝐫𝐚𝐫𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐠𝐞𝐧𝐞𝐭𝐢𝐜 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃 𝟑𝟑𝟒.𝟕 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟑. 𝐈𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐭𝐨 𝐔𝐒𝐃 𝟑,𝟏𝟎𝟐.𝟒 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒, 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐢𝐧𝐠 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 𝐨𝐟 𝟏𝟑.𝟐% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟐.

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧
Roughly 80% of rare diseases have genetic inception, predominantly monogenic. Therefore, genetic testing is imperative for the verification of clinical diagnostics and to guarantee accurate genetic counseling. Next-generation sequencing (NGS) has sanctioned an insurrection in genetic diseases, particularly in rare diseases. But their intricacy renders diagnostics arduous even with the arrival of NGS.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-sample

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
• Several reasons have contributed to the expansion of the rare disease genetic testing market in recent years. Among these is the next-generation sequencing (NGS), which has profoundly improved the preciseness, momentum, and economy of genetic testing.

• The market size will expand due to the surge in customized medicines and earmarked therapies. Genetic testing permits healthcare experts to recognize particular genetic mutations or differences accountable for rare diseases, easing customized cure plans designed for individual patients.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
The growing identification of the clinical utility of genetic testing for determining and handling rare diseases. Here is the list of the leading companies operating in the rare disease genetic testing market:

• 3billion, Inc.
• Ambry Genetics
• Arup Laboratories
• Artemis DNA
• Centogene N.V.
• Color Genomics, Inc.
• Coopersurgical, Inc.
• Eurofins Scientific
• Fulgent Genetics Inc.
• Genomenon
• Health Network Laboratories
• Invitae Corp.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐚 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐁𝐞𝐟𝐨𝐫𝐞 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞:
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-discount-pricing

𝐑𝐚𝐫𝐞 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐆𝐞𝐧𝐞𝐭𝐢𝐜 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬
• The endocrine and metabolism diseases segment accounted for the significant market share in 2022. Rising interest in comprehending endocrine disorders' molecular and genetic etiology, such as Cushing's syndrome, is fueling this trend.

• Next-generation sequencing segment is anticipated to hold a significant market share during the forecast period due to adopting next-generation sequencing-based gene panels across various applications, including neurologic disease, cancer, pediatric conditions, cardiovascular disease, psychiatric disorders, and other disease testing.

• The molecular genetic tests segment is anticipated to grow fastest in the market due to technological advancements, and clinical expertise in managing high-throughput technologies is credited for driving this growth.

• Research Laboratories & CROs segment holds the largest revenue share due to laboratories playing a crucial role in the market, offering diverse testing specialties such as molecular, chromosomal, and biochemical genetic tests.

• North America is expected to hold the largest market share over the forecast period. The rising prevalence of rare diseases, extensive disease registries, dedicated research and development centers for ultra-rare diseases, and substantial investments in disease detection are driving factors.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
The rare disease genetic testing market analysis is mainly based on disease type, technology, specialty, end-use, and region. Based on disease type, the endocrine and metabolism diseases segment witnessed the fastest growth. There is a growing demand for comprehending the molecular and genetic sources of endocrine diseases like Cushing's syndrome.

Moreover, according to technology, the next-generation sequencing segment holds a significant revenue share. Acquiring next-generation sequencing-dependent gene panels for several applications such as neurologic disease, cancer, pediatric conditions, cardiovascular disease, psychiatric disorders, and other disease testing has been a prominent driver for the segment's growth.

Rare Disease Genetic Testing, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)
 Neurological Disease
 Immunological Disorders
 Hematology Diseases
 Endocrine & Metabolism Diseases
 Cancer
 Musculoskeletal Disorders
 Cardiovascular Disorders
 Dermatology Disease
 Others

Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2019 - 2032)
 Next-Generation Sequencing
o Whole Exome
o Whole Genome
 Array Technology
 PCR-based Testing
 FISH
 Sanger Sequencing
 Karyotyping

Rare Disease Genetic Testing, Speciality Outlook (Revenue - USD Million, 2019 - 2032)
 Molecular Genetic Tests
 Chromosomal Genetic Tests
 Biochemical, Genetic Tests

Rare Disease Genetic Testing, End-use Outlook (Revenue - USD Million, 2019 - 2032)
 Research Laboratories & Cros
 Hospitals & Clinics
 Diagnostic Laboratories

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:
https://www.polarismarketresearch.com/press-releases/rare-disease-genetic-testing-market

𝐆𝐞𝐨𝐠𝐫𝐚𝐩𝐡𝐢𝐜𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
3D Cell Culture Market
https://www.polarismarketresearch.com/industry-analysis/3d-cell-culture-market

Breast Lesion Localization Methods Market
https://www.polarismarketresearch.com/industry-analysis/breast-lesion-localization-methods-market

Geriatric Medicines Market
https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market

Xerostomia Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.